Prognostic Value of MIP-1α, TGF-β2, sELAM-1, and sVCAM-1 in Patients with Gram-Positive Sepsis
- 31 May 1998
- journal article
- Published by Elsevier BV in Clinical Immunology and Immunopathology
- Vol. 87 (2), 139-144
- https://doi.org/10.1006/clin.1998.4523
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Increased Serum Concentration of Soluble CD14 Is a Prognostic Marker in Gram-Positive SepsisClinical Immunology and Immunopathology, 1996
- Serum Concentrations of MIP-1 α and Interleukin-8 in Patients Suffering from Acute Plasmodium falciparum MalariaClinical Immunology and Immunopathology, 1995
- An overview of mortality risk prediction in sepsisCritical Care Medicine, 1995
- Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndromeCritical Care Medicine, 1994
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?The Journal of Experimental Medicine, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Cytokines and septic shockDiagnostic Microbiology and Infectious Disease, 1990
- Gram-positive bacteraemia in granulocytopenic cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1990
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989